entity,start_date,end_date,context,AARSRAPPORT_html,AARSRAPPORT_pdf,AARSRAPPORT_xml,AddressOfAuditorCountry,AddressOfAuditorDistrictName,AddressOfAuditorPostCodeIdentifier,AddressOfAuditorStreetBuildingIdentifier,AddressOfAuditorStreetName,AddressOfReportingEntityDistrictName,AddressOfReportingEntityPostCodeIdentifier,AddressOfReportingEntityStreetBuildingIdentifier,AddressOfReportingEntityStreetName,AddressOfSubmittingEnterprisePostcodeAndTown,AddressOfSubmittingEnterpriseStreetAndNumber,AddresseeOfAuditorsReportOnAuditedFinancialStatements,AmortisationOfIntangibleAssets,ClassOfReportingEntity,ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement,ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults,DateOfApprovalOfAnnualReport,DateOfFoundationOfReportingEntity,DateOfGeneralMeeting,DescriptionOfAuditor,DescriptionOfClassOfIssuedShares,DescriptionOfMethodsOfCurrentTaxReceivablesAndLiabilities,DescriptionOfMethodsOfDividends,DescriptionOfMethodsOfImpairmentLossesAndDepreciation,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables,DescriptionOfQualificationsOfAuditedFinancialStatements,DisclosureOfEmployeeBenefitsExpense,ExplanationOfNotDisclosingCashFlowsStatements,ExplanationOfPrepayments,HomepageOfReportingEntity,IdentificationNumberCvrOfAuditFirm,IdentificationNumberCvrOfReportingEntity,IdentificationNumberCvrOfSubmittingEnterprise,IdentificationNumberOfAuditor,IdentificationOfApprovedAnnualReport,IdentificationOfAuditedFinancialStatements,InformationOnTypeOfSubmittedReport,ManagementsStatementAboutManagementsReview,NameAndSurnameOfAuditor,NameAndSurnameOfChairmanOfGeneralMeeting,NameAndSurnameOfMemberOfExecutiveBoard,NameOfReportingEntity,NameOfSubmittingEnterprise,OpinionOnAuditedFinancialStatements,PlaceOfSignatureOfStatement,PrecedingReportingPeriodStartDate,PredingReportingPeriodEndDate,ProfitLoss,RecommendationForApprovalOfAnnualReportByGeneralMeeting,RegisteredOfficeOfReportingEntity,ReportingPeriodEndDate,ReportingPeriodStartDate,RetrospectiveInformationOnContributedCapital,SelectedElementsFromReportingClassC,TelephoneNumberOfReportingEntity,TitleOfMemberOfSupervisoryBoard,TypeOfAuditorAssistance,_id,_index,_score,cvrNummer,indlaesningsId,indlaesningsTidspunkt,offentliggoerelsesTidspunkt,offentliggoerelsestype,omgoerelse,regNummer,regnskabsperiode_slutDato,regnskabsperiode_startDato,sagsNummer,sidstOpdateret,AdjustmentsForCurrentTaxRelatingToTaxRateChangesOrImpositionOfNewTaxes,AdjustmentsForDeferredTax,AverageNumberOfEmployees,CurrentTaxExpense,DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss,EmployeeBenefitsExpense,EquityRatio,ExchangeRateLoss,ExchangeRateProfit,GrossProfitLoss,InterestExpenseAssignedToGroupEnterprises,OtherFinanceExpenses,OtherFinanceIncome,OtherInterestExpenses,PostemploymentBenefitExpense,ProfitLossFromOrdinaryActivitiesBeforeTax,ProfitLossFromOrdinaryOperatingActivities,ResultsFromNetFinancials,ReturnOnCapitalEmployed,ReturnOnEquity,TaxExpense,TaxExpenseOnOrdinaryActivities,WagesAndSalaries,Assets,ContributedCapital,CurrentAssets,CurrentDeferredTaxAssets,DeferredIncomeAssets,Equity,Goodwill,IntangibleAssets,Inventories,LiabilitiesAndEquity,LiabilitiesOtherThanProvisions,LongtermLiabilitiesOtherThanProvisions,ManufacturedGoodsAndGoodsForResale,NoncurrentAssets,OtherLongtermPayables,OtherShorttermPayables,PaidContributedCapital,Provisions,ProvisionsForDeferredTax,RetainedEarnings,ShorttermLiabilitiesOtherThanProvisions,ShorttermPayablesToGroupEnterprises,ShorttermPrepaymentsReceivedFromCustomers,ShorttermReceivables,ShorttermReceivablesFromGroupEnterprises,ShorttermTaxPayables,ShorttermTradePayables,ShorttermTradeReceivables,AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets,IntangibleAssetsGross,SignatureOfAuditorsDate,SignatureOfAuditorsPlace,NameOfAuditFirm,NameAndSurnameOfMemberOfSupervisoryBoard
73131510,2017-01-01,2017-12-31,c106,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,10743000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-01-01,2017-12-31,c537,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,10743000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,548000.0,146000.0,9.0,3061000.0,1563000.0,8811000.0,57.3,1000.0,4000.0,25589000.0,720000.0,721000.0,4000.0,0.0,874000.0,14498000.0,15215000.0,-717000.0,22.7,32.5,3755000.0,3755000.0,7937000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-12-31,2017-12-31,c109,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,67147000.0,2000000.0,56200000.0,0.0,421000.0,38450000.0,10947000.0,10947000.0,4054000.0,67147000.0,28277000.0,26000.0,4054000.0,10947000.0,26000.0,8277000.0,2000000.0,420000.0,420000.0,36450000.0,28251000.0,17855000.0,545000.0,52146000.0,3590000.0,1397000.0,177000.0,48135000.0,,,,,,
73131510,2017-12-31,2017-12-31,c233,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26000.0,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-01-01,c0,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-01-01,c20,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,36450000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-01-01,c331,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4691000.0,15638000.0,,,,
73131510,2018-01-01,2018-12-31,c105,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,4791000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-12-31,c21,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,4791000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-12-31,c338,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-12-31,c539,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,7936000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,9.0,,,,67.7,,,,,,,,,,9760000.0,-249000.0,23.9,33.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-12-31,c542,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,3313000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,9.0,,,,33.4,,,,,,,,,,4393000.0,-437000.0,7.4,18.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-12-31,c545,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,2111000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,7.0,,,,60.0,,,,,,,,,,3311000.0,-21000.0,12.1,25.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-01-01,2018-12-31,c65,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,4791000.0,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,0.0,-471000.0,9.0,1831000.0,1564000.0,8279000.0,71.2,7000.0,10000.0,16137000.0,112000.0,153000.0,10000.0,34000.0,991000.0,6151000.0,6294000.0,-143000.0,10.4,11.7,1360000.0,1360000.0,7288000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019-04-11,Copenhagen,,
73131510,2018-01-01,2018-12-31,c67,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,KPMG Statsautoriseret Revisionspartnerselskab,
73131510,2018-01-01,2018-12-31,c68,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Jeanette Sandholmen
73131510,2018-01-01,2018-12-31,c69,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Tiina Marjatta Puhakka
73131510,2018-01-01,2018-12-31,c70,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,RenÃ©e Christine Tunold
73131510,2018-01-01,2018-12-31,c83,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-12-31,2018-12-31,c110,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,60750000.0,2000000.0,51367000.0,51000.0,1420000.0,43241000.0,9383000.0,9383000.0,3721000.0,60750000.0,17509000.0,65000.0,3721000.0,9383000.0,65000.0,14671000.0,2000000.0,0.0,0.0,41241000.0,17444000.0,1882000.0,505000.0,47646000.0,6493000.0,206000.0,180000.0,39682000.0,,,,,,
73131510,2018-12-31,2018-12-31,c119,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-12-31,2018-12-31,c2,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-12-31,2018-12-31,c22,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41241000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-12-31,2018-12-31,c339,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9383000.0,,,,,,,,,,,,,,,,,,,,,6255000.0,15638000.0,,,,
73131510,2018-12-31,2018-12-31,c541,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,40901000.0,,,,,27707000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-12-31,2018-12-31,c544,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,59239000.0,,,,,19771000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-12-31,2018-12-31,c547,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,27445000.0,,,,,16458000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2018-12-31,2018-12-31,c58,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzYzLzdjLzMyL2IwLzcxMmItNDZjZi1iZmU2LTZhMjYzMzY1ODFmOA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2FmLzQxL2VmL2Q5LzQ4MzQtNGM0Yy04YjQ2LTRlZTI5M2YzZDkwMQ.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,1564000.0,"Regnskabsklasse C, mellemstor virksomhed",The Annual Report is prepared in accordance with the Danish Financial Statements Act.,In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2018 of the Company and of the results of the Company operations for 2018.,2019-04-11,1982-12-31,2019-04-11,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,"Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets.",Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Prepayments comprise prepaid expenses concerning subsequent financial years.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",Remuneration to the Executive Board has not been disclosed in accordance with section 98 B(3) of the Danish Financial Statements Act.,"With reference to section 86(4) of the Danish Financial Statements Act and to the cash flow statement included in the consolidated financial statements of Merck KGaA, the Company has not prepared a cash flow statement.",Prepayments consist of prepaid expenses concerning subsequent financial years.,www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Executive Board and Board of Directors have today considered and adopted the Annual Report of Merck Life Science A/S for the financial year 1 January - 31 December 2018.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2018, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, Management's Review includes a true and fair account of the matters addressed in the Review.",Kenn Wolff Hansen,Susanne Krogh,Tiina Marjatta Puhakka,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2018 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2018 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2017-01-01,2017-12-31,,We recommend that the Annual Report be adopted at the Annual General Meeting.,Gladsaxe,2018-12-31,2018-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,Chairman,RevisionspÃ¥tegning,urn:ofk:oid:27030121,indberetninger-20180424,2.5124266,73131510.0,AWpVNYLjRYGX6_YTHIfD,2019-04-25T15:56:05.938Z,2019-04-25T15:55:30.563Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-AZ-17-CH,2019-04-25T15:55:30.908Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65000.0,,,,,,,,,,,,,,,,,,,,,,
